CVE-2020-27374
HIGHCVSS 7.5/10EPSS 0.89%
Last modified
CVE-2020-27374 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. Dr Trust USA iCheck Connect BP Monitor BP Testing 118 1.2.1 is vulnerable to a Replay Attack to BP Monitoring.. EPSS estimates a 0.89% chance of exploitation in the next 30 days.
Description
Dr Trust USA iCheck Connect BP Monitor BP Testing 118 1.2.1 is vulnerable to a Replay Attack to BP Monitoring.
Metrics
CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Drtrustusa | Icheck Connect Bp Monitor Bp Testing 118 Firmware | 1.2.1 |
References
- http://dr.comProduct
- https://nvermaa.medium.com/cve-on-radio-technology-d-4b65efa1ba5cExploit, Third Party Advisory
- http://dr.comProduct
- https://nvermaa.medium.com/cve-on-radio-technology-d-4b65efa1ba5cExploit, Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2020-27374?
Dr Trust USA iCheck Connect BP Monitor BP Testing 118 1.2.1 is vulnerable to a Replay Attack to BP Monitoring.
How severe is CVE-2020-27374?
CVE-2020-27374 has a CVSS score of 7.5/10 (HIGH severity). The EPSS model estimates a 0.89% probability of exploitation in the next 30 days.
How do I fix CVE-2020-27374?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2020-27374?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST